Article thumbnail
Location of Repository

The combinational effect of cardiac and biochemical markers in diabetic patients with cardiovascular disease

By Int J Cur Bio Med Sci. Athimoolam Ambika Babu Shankar Ponnusha Sathiyamoorthy Subramaniyam Farook J YY Rao Palanisamy Pasupathi


Background: Clinicopathological correlations, as well as several angiographic studies, suggest that diabetic patients have more extensive atherosclerotic disease, affecting the coronary arteries in particular. We sought to examine the combinational effect of cardiac and biochemical markers in diabetic patients with cardiovascular disease.\ud Method: The study population constituted 50 healthy subjects, 50 cardiovascular subjects with diabetes and 50 cardiovascular subjects without diabetes. The population was subjected to biochemical and cardiac marker analysis and the results were verified.\ud Results and discussion: Studies suggest that glycated hemoglobin values in the abnormal range can identify persons at increased risk for coronary heart disease, stroke, and death before the diagnosis of diabetes, indicating that glycated hemoglobin is a useful marker of cardiovascular risk and death from any cause.\u

Publisher: CurrentSciDirect Publications
Year: 2011
OAI identifier:

Suggested articles


  1. A comparison of results for cholesterol in human serum by the reference method and by the definitive method of the National Reference System for cholesterol. Clin Chem.
  2. (2004). C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care.
  3. Coronary atherosclerosis in diabetes mellitus: a post-mortem study.
  4. (1975). Diabetes and the heart. doi
  5. (2006). Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care.
  6. (2001). Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease,
  7. Endothelial dysfunction in normal and abnormal glucose metabolism.
  8. (2000). Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem.
  9. (2006). Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type II diabetes mellitus. Mediators Inflamm.
  10. Glycated haemoglobin estimation in the 1990's: A review of assay methods and clinical interpretation. In:
  11. High-sensitivity C - reactive protein as Cardiovascular risk marker in patients with diabetes mellitus.
  12. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37o C. Part 6, Reference procedure for the measurement of catalytic concentration of gamma glutamyltransferase. Clin Chem Lab Med.
  13. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome.
  14. (2008). Intensification of oxidative stress and inflammation in type II diabetes despite antihyperglycemic treatment. Cardiovasc Diabetol.
  15. Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment.
  16. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
  17. Morbidity and mortality in diabetics in a general population: sixteen year follow-up experience in the Framingham study.
  18. Nitric oxide and peroxynitrite in health and disease. Physiol Rev.
  19. Oxidized phospholipids as modulators of inflammation in atherosclerosis.
  20. (2008). Plasma glutathione level are independently associated with Gamma Glutamyl transferase activity in subjects with cardiovascular risk factors. Free Rad Res.
  21. (2007). Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care.
  22. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.
  23. Serum lipids and glucose control: the search for diabetes in youth study. Arch Pediatr Adolesc Med .2007;161 :
  24. The effect of glycemic control in type II diabetic patients with diabetes-related dyslipidemia.
  25. The evaluation of cardiac and peripheral arterial disease in patients with diabetes mellitus. Endocr Res.
  26. (2007). The role of glucose as an independent cardiovascular risk factor. Curr Diab Rep.
  27. (1997). Thompsion EJ, Heales SJR. Adaption of nitric reductase and Griess reaction methods for measurement of serum nitrate plus nitrite levels. Ann Clin Biochem.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.